APLICATIONS
Ballad’s role in blood plasma COVID-19 study unaffected by FDA ruling
The U.S. Food and Drug Administration has reportedly put a hold on granting emergency authorization to use blood plasma as a treatment for the novel coronavirus, though the Mayo Clinic
